WMSA
EIGR
Weiss Multi-Strategy Advisers’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-48,894
| Closed | -$34K | – | 708 |
|
|
2023
Q2 | $34K | Sell |
48,894
-5,160
| -10% | -$3.59K | ﹤0.01% | 566 |
|
|
2023
Q1 | $48K | Sell |
54,054
-10,946
| -17% | -$9.72K | ﹤0.01% | 558 |
|
|
2022
Q4 | $77K | Sell |
65,000
-35,000
| -35% | -$41.5K | ﹤0.01% | 547 |
|
|
2022
Q3 | $753K | Sell |
100,000
-40,749
| -29% | -$307K | 0.02% | 491 |
|
|
2022
Q2 | $887K | Sell |
140,749
-14,251
| -9% | -$89.8K | 0.03% | 479 |
|
|
2022
Q1 | $1.29M | Sell |
155,000
-54,428
| -26% | -$452K | 0.03% | 448 |
|
|
2021
Q4 | $1.09M | Sell |
209,428
-3,572
| -2% | -$18.5K | 0.02% | 446 |
|
|
2021
Q3 | $1.42M | Buy |
213,000
+6,000
| +3% | +$40.1K | 0.03% | 442 |
|
|
2021
Q2 | $1.76M | Buy |
207,000
+7,000
| +4% | +$59.7K | 0.04% | 403 |
|
|
2021
Q1 | $1.77M | Buy |
200,000
+2,453
| +1% | +$21.7K | 0.04% | 406 |
|
|
2020
Q4 | $2.43M | Buy |
197,547
+5,547
| +3% | +$68.2K | 0.05% | 362 |
|
|
2020
Q3 | $1.56M | Buy |
192,000
+7,000
| +4% | +$57K | 0.04% | 360 |
|
|
2020
Q2 | $1.78M | Buy |
185,000
+29,000
| +19% | +$278K | 0.05% | 334 |
|
|
2020
Q1 | $1.06M | Buy |
156,000
+6,000
| +4% | +$40.8K | 0.04% | 293 |
|
|
2019
Q4 | $2.24M | Buy |
150,000
+10,000
| +7% | +$149K | 0.04% | 349 |
|
|
2019
Q3 | $1.44M | Buy |
140,000
+10,000
| +8% | +$103K | 0.03% | 321 |
|
|
2019
Q2 | $1.38M | Buy |
130,000
+25,000
| +24% | +$265K | 0.04% | 282 |
|
|
2019
Q1 | $1.47M | Hold |
105,000
| – | – | 0.04% | 296 |
|
|
2018
Q4 | $1.07M | Buy |
105,000
+70,000
| +200% | +$711K | 0.04% | 243 |
|
|
2018
Q3 | $420K | Buy |
+35,000
| New | +$420K | 0.01% | 369 |
|
|
2014
Q4 | – | Sell |
-10,000
| Closed | -$105K | – | 513 |
|
|
2014
Q3 | $105K | Buy |
+10,000
| New | +$105K | ﹤0.01% | 431 |
|